Palliative radiation therapy of bladder cancer

Introduction. One of the problems of urologic oncology is that patients with bladder cancer (BC) show up late for appointments, which leads to increased numbers of patients with advanced cancer stages accompanied by symptoms considerably reducing their quality of life. In most similar cases, external beam radiation therapy (EBRT) may be given with palliative intent to lessen or relieve the local symptoms of disease and to deliver the highest possible dose of radiation to bladder tumor.

Objective: to assess the efficacy and toxicity of palliative EBRT in patients with BC.

Materials and methods. Outcomes of palliative EBRT that had been given to 103 patients with BC were analyzed. Poor somatic health status of these patients caused by underlying disease or accompanying pathology made radical treatment impossible.

Results. During EBRT treatment, hematuria was stopped in 56 (72.7 %) and reduced in 21 (27.3 %) patients. After completing EBRT, bladder pain syndrome was relieved in 13 (76.5 %) of 17 patients, but in 1 patient the pain got worse, and in 3 (17.6 %) patients no changes in this symptom occurred. Acute bladder reactions were observed in 37 (35.9 %) patients: grade I–II (RTOG) in 32 (31.1 %) patients and grade III–IV in 5 (4.8 %) patients. Acute grade I–II rectitis was noted in 10 (9.7 %) patients. Late grade I–II bladder complications (RTOG/EORTC) occurred in 16 (15.5 %) patients, and late rectal complications in 2 (1.9 %) patients. Due to relief of local symptoms and improvement of somatic health status in 16 (15.5 %) patients, it was possible to perform radical treatment for BC. At 12 months after treatment, objective tumor response was achieved in 34 (33.0 %) and stable disease in 14 (13.6 %) BC patients.

Conclusion. Radiation therapy is an effective method of palliative care of patients with advanced BC and marked local symptoms. In most cases, EBRT can help stop or reduce hematuria and pain as well as improve quality of patient life. Therefore, it is necessary to develop methods of effective palliative care for patients with complicated advanced BC. A personalized approach to optimize programs palliative treatment of BC is a promising direction for further research.

1. Efstathiou J. A., Zietman A. L., Coen J. J., Shipley W. U. Bladder cancer. In book: Clinical radiation oncology. 3rd edn. Eds. L. L. Gunderson, J. E. Tepper. Philadelphia: Elsevier saunders, 2012. Pp. 1099–1123.

2. Griffiths T. R. Current perspectives in bladder cancer management. Int J Clin Pract 2013;67(5):435–48. DOI: 10.1111/ijcp.12075. PMID: 23137019.

3. Lutz S. T., Chow E. L., Hartsell W. F., Konski A. A. A review of hypofractionated palliative radiotherapy. Cancer 2007;109(8):1462–70. DOI: 10.1002/cncr.22555. PMID: 17330854.

4. Petrovich Z., Stein J. P., Jozsef G., Formenti S. C. Bladder. In book: Principles and Practice of Radiation Oncology. 5th edn. Eds.: C. A. Perez, L. W. Brady, E. D. Halperin. Philadelphia: Lippincott Williams & Wilkins, 2008. Pp. 1412–1438.

5. Abt D., Bywater M., Engeler D. S., Schmid H. P. Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol 2013;20(7):651–60. DOI: 10.1111/iju.12113. PMID: 23387805.

6. Caravatta L., Padula G. D., Macchia G. et al. Short-course accelerated radiotherapy in palliative treatment of advanced pelvis malignancies: a phase I study. Int J Radiat Oncol Biol Phys 2012;83(5):627–31. DOI: 10.1016/j.ijrobp.2011.10.081. PMID: 22580117.

7. Donato V., Valeriani M., Zurlo A. Short course radiation therapy for elderly cancer patients. Evidences from the literature review. Crit Rev Oncol Hematol 2003;45(3):305–11. DOI: 10.1016/S1040–8428(02)00082–3. PMID: 12633841.

8. Srinivasan V., Brown C. H., Turner A. G. A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer. J Clin Oncol 1994;6(1):11–3. PMID: 7513538.

9. Duchesne G. M., Bolger J. J., Griffiths G. O. et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int J Radiat Oncol Biol Phys 2000;47(2):379–88. DOI: 10.1016/S0360–3016(00)00430–2. PMID: 10802363.

10. Holmang S., Borghede G. Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma. J Urol 1996;155(1):100–2. DOI: 10.1016/S0022– 5347(01)665571. PMID: 7490801.

11. Wijkstrom H., Naslund I., Ekman P. et al. Shot-term radiotherapy as palliative treatment in patients with transitional cell bladder cancer. Brit J Urol 1991;67(1): 74–8. PMID: 1704277.

12. Salminen E. Inconventional fractionation for palliative radiotherapy of urinary bladder cancer. A retrospective review of 94 patients. Acta Oncol 1992;31(4):449–54. PMID: 1378746.

13. McLaren D. B., Morrey D., Mason M. D. Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother Oncol 1997;43(2):171–4. PMID: 9192963.

14. Jose C. C., Price A., Norman A. et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. J Clin Oncol 1999;11(5):330–3. PMID: 10591821.

15. Kouloulias V., Tolia M., Kolliarakis N. et al. Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer. Int Braz J Urol 2013;39(1):77–82. DOI: 10.1590/S1677–5538. PMID: 23489500.

16. Dirix P., Vingerhoedt S., Joniau S. et al. Hypofractionated palliative radiotherapy for bladder cancer. Support Care Cancer 2016;24(1):181–6. DOI: 10.1007/s00520-015-2765-y. PMID: 25975677.

17. Fossa S. D., Hosbach G. Short-term moderate-dose pelvis radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect. Acta Oncol 1991;30(6):735–8. PMID: 1958395.

18. Lacarriere E., Smaali C., Benyoucef A. et al. The efficacy of hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery. Int Braz J Urol 2013;39(6):808–16. DOI: 10.1590/S1677–5538. PMID: 24456773.

19. Иванов В. К. Математическое моделирование и оптимизация лучевой терапии опухолей. М.: Энергоатомиздат, 1986. 145 с. [Ivanov V. K. Mathematical modeling and optimization of radiation therapy of tumors. Moscow: Energo atomizdat, 1986. 145 p. (In Russ.)].

20. Jones J. A., Lutz S. T., Chow E., Johnstone P. A. Palliative radiotherapy at the end of life: a critical review. CA Cancer J Clin 2014;64(5):295–310. DOI: 10.3322/caac.21242. PMID: 25043971.

21. Rades D., Manig L., Janssen S. et al. A survival score for patients assigned to palliative radiotherapy for metastatic bladder cancer. Anticancer research 2017;37(3):1481–4. DOI: 10.21873/anticanres.11473. PMID: 28314321.

22. Каприн А. Д., Галкин В. Н., Жаворонков Л. П. и др. Синтез фундаментальных и прикладных исследований – основа обеспечения высокого уровня научных результатов и внедрения их в медицинскую практику. Радиация и риск (Бюллетень Национального радиационно-эпидемиологического регистра) 2017;26(2):26–40. [Kaprin A. D., Galkin V. N., Zhavoronkov L. P. et al. Synthesis of basic and applied research is the basis of obtaining highquality findings and translating them into clinical practice. Radiatsiya i risk (Byulleten’ Natsional’nogo radiatsionnoepidemiologicheskogo registra) = Radiation and Risk (Bulletin of the National Radiation and Epidemiological Registry) 2017;26(2): 26–40. (In Russ.)]. DOI: 10.21870/0131-3878-2017-26-2-26-40.